Follicular Lymphoma
Follicular lymphoma is a type of non-Hodgkin lymphoma that typically grows slowly and affects the lymphatic system, often presenting with swollen lymph nodes and other systemic symptoms.
We are examining how a new intravenous treatment affects adults with relapsed or refractory diffuse large B-cell lymphoma, follicular lymphoma, or chronic lymphocytic leukemia. The study looks at potential side effects and changes in disease activity.
Health conditions and diseases that the clinical trial is designed to study and treat.
Follicular lymphoma is a type of non-Hodgkin lymphoma that typically grows slowly and affects the lymphatic system, often presenting with swollen lymph nodes and other systemic symptoms.
Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow, leading to an overproduction of abnormal lymphocytes, which can cause symptoms like fatigue and swollen lymph nodes.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive form of non-Hodgkin lymphoma characterized by the rapid growth of large B-cells, often presenting with swollen lymph nodes and systemic symptoms.
B-cell malignancies encompass a range of cancers that originate from B-lymphocytes, including various types of lymphomas and leukemias, often leading to symptoms like swollen lymph nodes and fatigue.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.